dr. rischin discusses role of cemiplimab in cervical cancer
Published 5 years ago • 88 plays • Length 0:42Download video MP4
Download video MP3
Similar videos
-
1:16
dr. rischin discusses the future of cemiplimab in cervical cancer
-
1:13
dr. rischin discusses cemiplimab in cervical cancer
-
1:28
dr. rischin discusses cemiplimab in cutaneous squamous cell carcinoma
-
0:37
dr. rischin on the fda approval of cemiplimab for cscc
-
1:40
dr. tewari on trial with cemiplimab in recurrent or metastatic cervical cancer
-
0:59
findings for cemiplimab in advanced or recurrent cervical cancer
-
1:46
dr. tewari on the trial design with cemiplimab in cervical cancer
-
2:02
danny rischin, md, discusses unmet needs and how advanced cscc was treated prior to cemiplimab
-
8:52
frontline therapies for metastatic cervical cancer
-
0:54
dr. randall on emerging treatment strategies in cervical cancer
-
2:57
danny rischin, md, shares long-term outcomes of the clinical study regarding advanced cscc
-
1:58
dr. rischin on keynote-048 results in head and neck squamous cell carcinoma
-
7:34
cemiplimab post-treatment considerations
-
1:36
dr. michael birrer on immunotherapy potential in cervical cancer
-
0:42
combining cemiplimab and isa101b for the treatment of recurrent/metastatic hpv16 cervical cancer
-
2:19
dr. pavlick on the safety profile of cemiplimab in cscc
-
1:38
dr. pavlick on longer follow-up data with cemiplimab in cscc
-
0:21
integrating cemiplimab isa101b into the treatment paradigm for recurrent hpv16 cervical cancer
-
7:01
cemiplimab phase i trial